At #AACR26, Dr. Ignacio Garrido-Laguna, Chair of Early Therapeutics Development @MoffittNews joined me to discuss exciting work on CCR8-targeting therapies, an emerging approach to overcome immunosuppressive regulatory T cells and enhance #immunotherapy responses.

#AACR26 #MoffittAACR26